v1
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA2.
NobleIDNI7P36W07R47S29
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260526/EAF1663D)